WO2009140929A1 - Procédé de co-production de 1,3-propanediol, 2,3-butanediol et d'acide polyhydroxypropionique par fermentation de bactéries produites par génie génétique - Google Patents
Procédé de co-production de 1,3-propanediol, 2,3-butanediol et d'acide polyhydroxypropionique par fermentation de bactéries produites par génie génétique Download PDFInfo
- Publication number
- WO2009140929A1 WO2009140929A1 PCT/CN2009/072615 CN2009072615W WO2009140929A1 WO 2009140929 A1 WO2009140929 A1 WO 2009140929A1 CN 2009072615 W CN2009072615 W CN 2009072615W WO 2009140929 A1 WO2009140929 A1 WO 2009140929A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pdo
- fermentation
- php
- bdo
- genetically engineered
- Prior art date
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 64
- 230000004151 fermentation Effects 0.000 title claims abstract description 64
- 241000894006 Bacteria Species 0.000 title claims abstract description 44
- 238000000034 method Methods 0.000 title claims abstract description 27
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 19
- 238000010353 genetic engineering Methods 0.000 title claims abstract description 13
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 title abstract description 7
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 title abstract description 7
- 229920000166 polytrimethylene carbonate Polymers 0.000 title abstract description 7
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 title abstract description 6
- 239000002253 acid Substances 0.000 title abstract description 4
- 229940035437 1,3-propanediol Drugs 0.000 title description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 95
- 235000011187 glycerol Nutrition 0.000 claims abstract description 35
- 108700023483 L-lactate dehydrogenases Proteins 0.000 claims abstract description 20
- 238000000605 extraction Methods 0.000 claims abstract description 17
- 239000006227 byproduct Substances 0.000 claims abstract description 11
- 238000000909 electrodialysis Methods 0.000 claims abstract description 11
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 claims abstract description 7
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 claims abstract description 7
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 claims abstract description 6
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000005516 coenzyme A Substances 0.000 claims abstract description 6
- 229940093530 coenzyme a Drugs 0.000 claims abstract description 6
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 claims abstract description 6
- 102000003855 L-lactate dehydrogenase Human genes 0.000 claims abstract description 5
- 239000000047 product Substances 0.000 claims description 28
- 239000013598 vector Substances 0.000 claims description 19
- 239000002609 medium Substances 0.000 claims description 12
- 238000010276 construction Methods 0.000 claims description 10
- 239000013612 plasmid Substances 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- -1 sodium succinate organic acid salt Chemical class 0.000 claims description 9
- 241000588724 Escherichia coli Species 0.000 claims description 8
- 241000588748 Klebsiella Species 0.000 claims description 8
- 239000012634 fragment Substances 0.000 claims description 8
- 239000003513 alkali Substances 0.000 claims description 7
- 238000002474 experimental method Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 239000013599 cloning vector Substances 0.000 claims description 5
- 230000001419 dependent effect Effects 0.000 claims description 5
- 238000004821 distillation Methods 0.000 claims description 5
- 239000013604 expression vector Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 241000588923 Citrobacter Species 0.000 claims description 4
- 241000588914 Enterobacter Species 0.000 claims description 4
- 108010010718 poly(3-hydroxyalkanoic acid) synthase Proteins 0.000 claims description 4
- 239000000758 substrate Substances 0.000 claims description 4
- 241000193403 Clostridium Species 0.000 claims description 3
- 238000010564 aerobic fermentation Methods 0.000 claims description 3
- 230000033228 biological regulation Effects 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000012224 gene deletion Methods 0.000 claims description 3
- 239000003550 marker Substances 0.000 claims description 3
- 238000003259 recombinant expression Methods 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims description 2
- 241000588921 Enterobacteriaceae Species 0.000 claims description 2
- 241000232299 Ralstonia Species 0.000 claims description 2
- 241000607720 Serratia Species 0.000 claims description 2
- 239000003225 biodiesel Substances 0.000 claims description 2
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- 238000011033 desalting Methods 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims description 2
- 238000001471 micro-filtration Methods 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- 238000011218 seed culture Methods 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 229940074404 sodium succinate Drugs 0.000 claims description 2
- 238000000108 ultra-filtration Methods 0.000 claims description 2
- 230000004544 DNA amplification Effects 0.000 claims 2
- 238000010168 coupling process Methods 0.000 claims 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- 230000008878 coupling Effects 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 238000005868 electrolysis reaction Methods 0.000 claims 1
- 238000012262 fermentative production Methods 0.000 claims 1
- 239000002054 inoculum Substances 0.000 claims 1
- 239000012452 mother liquor Substances 0.000 claims 1
- 108091008146 restriction endonucleases Proteins 0.000 claims 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 abstract description 6
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 5
- 108010039731 Fatty Acid Synthases Proteins 0.000 abstract description 4
- 239000012528 membrane Substances 0.000 abstract description 3
- 229950006238 nadide Drugs 0.000 abstract description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 abstract description 2
- 230000007423 decrease Effects 0.000 abstract description 2
- 238000001914 filtration Methods 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 9
- ALRHLSYJTWAHJZ-UHFFFAOYSA-N 3-hydroxypropionic acid Chemical compound OCCC(O)=O ALRHLSYJTWAHJZ-UHFFFAOYSA-N 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 239000000178 monomer Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000004310 lactic acid Substances 0.000 description 6
- 235000014655 lactic acid Nutrition 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 108010025885 Glycerol dehydratase Proteins 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 229920000903 polyhydroxyalkanoate Polymers 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 208000037534 Progressive hemifacial atrophy Diseases 0.000 description 4
- 239000005515 coenzyme Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000012017 passive hemagglutination assay Methods 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 239000005020 polyethylene terephthalate Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 3
- 102000004533 Endonucleases Human genes 0.000 description 3
- 108010042407 Endonucleases Proteins 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000013064 chemical raw material Substances 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 230000037353 metabolic pathway Effects 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- WTLNOANVTIKPEE-UHFFFAOYSA-N 2-acetyloxypropanoic acid Chemical compound OC(=O)C(C)OC(C)=O WTLNOANVTIKPEE-UHFFFAOYSA-N 0.000 description 2
- SJZRECIVHVDYJC-UHFFFAOYSA-N 4-hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 description 2
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical group CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- KKEYFWRCBNTPAC-UHFFFAOYSA-N Terephthalic acid Chemical compound OC(=O)C1=CC=C(C(O)=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 239000002360 explosive Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000000976 ink Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229920000520 poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Polymers 0.000 description 2
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229910052707 ruthenium Inorganic materials 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- NYHNVHGFPZAZGA-UHFFFAOYSA-N 2-hydroxyhexanoic acid Chemical compound CCCCC(O)C(O)=O NYHNVHGFPZAZGA-UHFFFAOYSA-N 0.000 description 1
- JRHWHSJDIILJAT-UHFFFAOYSA-N 2-hydroxypentanoic acid Chemical compound CCCC(O)C(O)=O JRHWHSJDIILJAT-UHFFFAOYSA-N 0.000 description 1
- AKXKFZDCRYJKTF-UHFFFAOYSA-N 3-Hydroxypropionaldehyde Chemical compound OCCC=O AKXKFZDCRYJKTF-UHFFFAOYSA-N 0.000 description 1
- BERBFZCUSMQABM-IEXPHMLFSA-N 3-hydroxypropanoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCO)O[C@H]1N1C2=NC=NC(N)=C2N=C1 BERBFZCUSMQABM-IEXPHMLFSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 241001528480 Cupriavidus Species 0.000 description 1
- 241000252867 Cupriavidus metallidurans Species 0.000 description 1
- 238000005698 Diels-Alder reaction Methods 0.000 description 1
- 241001646716 Escherichia coli K-12 Species 0.000 description 1
- 210000000712 G cell Anatomy 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229920001273 Polyhydroxy acid Polymers 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- VVSAAKSQXNXBML-PHDIDXHHSA-N [(2R,3R)-3-acetyloxybutan-2-yl] acetate Chemical compound CC(=O)O[C@H](C)[C@@H](C)OC(C)=O VVSAAKSQXNXBML-PHDIDXHHSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000002528 anti-freeze Effects 0.000 description 1
- 239000007798 antifreeze agent Substances 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- JBJSVEVEEGOEBZ-SCZZXKLOSA-K coenzyme B(3-) Chemical compound [O-]P(=O)([O-])O[C@H](C)[C@@H](C([O-])=O)NC(=O)CCCCCCS JBJSVEVEEGOEBZ-SCZZXKLOSA-K 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 229920006351 engineering plastic Polymers 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 239000002316 fumigant Substances 0.000 description 1
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 238000011331 genomic analysis Methods 0.000 description 1
- GFAZHVHNLUBROE-UHFFFAOYSA-N hydroxymethyl propionaldehyde Natural products CCC(=O)CO GFAZHVHNLUBROE-UHFFFAOYSA-N 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000002346 musculoskeletal system Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001020 poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/18—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/32—Processes using, or culture media containing, lower alkanols, i.e. C1 to C6
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
- C12P7/625—Polyesters of hydroxy carboxylic acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Definitions
- the invention belongs to the field of biochemical technology, and particularly provides a method for constructing genetic engineering bacteria fermentation and co-production of PDO, BDO and PHP; the PDO is abbreviated as 1, 3-propanediol, and BDO is abbreviated as 2,3-butanediol.
- PHP is a polymer (poly ⁇ -hydroxypropionic acid) produced by polymerization of a monomer which is ⁇ -hydroxypropionic acid.
- 1,3-propanediol is an important chemical raw material that can be used as an organic solvent in inks, printing and dyeing, coatings, lubricants, antifreeze and other industries.
- the main use of PDO is as a monomer for the synthesis of polyester and polyurethane, especially polybutylene terephthalate ( ⁇ ) formed by polymerization with terephthalic acid, showing a ratio of 1,2-propanediol, dibutyl Alcohol and ethylene glycol are more excellent properties of the polymer synthesized by the monomer.
- PTT polyethylene terephthalate
- PTT fiber has the advantages of abrasion resistance, low water absorption, low static electricity, etc., and can compete with nylon in the field of carpet. It can also be used for non-woven fabrics, engineering plastics, garments, home decoration, linings, fabrics, etc. with excellent properties.
- PTT was named one of the six major petrochemical products in the United States in 1998 and is considered to be an upgraded product of PET.
- Biosynthesis of PDO is produced by microbial disproportionation of glycerol.
- glycerol can be converted to PDO microorganisms are mainly anaerobic or facultative anaerobic bacteria, of which Klebsiella pneumoniae, Clostridium butyric and Citwbacter freundii have higher PDO conversion rate, and high tolerance to glycerin and product PDO, therefore has a high development value and application prospects.
- BDO 2,3-butanediol
- BDO is a by-product of the production of PDO by fermentation and is also an important chemical raw material. It is a colorless, odorless liquid that can be used as a fuel to prepare polymers, inks, perfumes, antifreeze agents, fumigants, moisturizers, softeners, plasticizers, explosives, and chiral carriers for pharmaceuticals. BDO can also be used as a valuable chemical raw material to synthesize other chemicals. For example, BDO dehydration can produce methyl ethyl ketone. The application of methyl ethyl ketone is quite extensive, and further dehydration can form 1, 3-butadiene.
- BD0 can be polymerized by Diels-Alder reaction to form styrene.
- BD0 is condensed with methyl ethyl ketone and hydrogenated to form octane, which can be used to produce high quality flying materials.
- BD0 reacts with acetic acid to form 2,3-butanediol diacetate, which can be added to the cream to improve flavor.
- acetic acid to form 2,3-butanediol diacetate, which can be added to the cream to improve flavor.
- due to its low yield in PDO fermentation it is generally not isolated and purified as a product.
- Poly- ⁇ -hydroxy fatty acid English name Polyhydroxyalkanoates, abbreviated as PHAs, generally refers to a biopolymer material obtained by dehydration and esterification of hydroxyl and carboxyl groups between monomeric ⁇ -hydroxy fatty acids. It has been found that ruthenium polyester has at least 125 different monomer structures, and new monomers are constantly being discovered.
- the ruthenium synthesized by microbes has some special properties including biodegradability, biocompatibility, piezoelectricity and optical activity.
- ⁇ Can meet the needs of a variety of human tissues and organs, such as: cardiovascular system, corneal pancreas, gastrointestinal system, kidney, genitourinary system, musculoskeletal system, nervous system, teeth and mouth, skin and so on.
- the products that have been commercialized mainly include PHB, PHBV and ⁇ ⁇ .
- the properties of the crucible can vary from hard to soft to elastic. There are many potential application prospects, and a large number of basic and application development studies are carried out at home and abroad.
- the simplest monomer of PHAs is ⁇ -hydroxypropionic acid, and the polymer produced by its polymerization is referred to as PHP (polyhydroxypropionic acid).
- PHP polyhydroxypropionic acid
- the direct monomer for PHA biosynthesis is ⁇ -hydroxyacyl-Coenzyme, a monomer of this type containing high-energy chemical bonds.
- sputum can be produced by glycerol metabolism intermediates (see Figure 1).
- Zeng et al [Sun JB., Heuvel J., Soucaille P., Qu Y., and Zeng AP Comparative Genomic Analysis of dha Regulon and Related Genes for Anaerobic Glycerol Metabolism in Bacteria. Biotechnol. Prog. 2003 19:263-272]
- the plasmid containing the gene encoding glycerol dehydratase and PDO oxidoreductase was inserted into the wild strain, and the activity of the two enzymes was greatly improved. However, in the actual fermentation process, the engineered bacteria did not Produces high concentrations of PDO.
- pneumoniae M5al Genetically engineered bacteria with loss of acetic acid, ethanol and lactic acid metabolic pathways, glycerol conversion rate increased, but the final concentration of PDO and production intensity decreased. [Yang Guang. 1, 3-propanediol-producing bacteria M. pneumoniae molecular breeding [ D]. Beijing: China Agricultural University, 2003].
- Huang Zhihua et al [Huang Zhihua, Zhang Yanping, Cao Zhuan et al. Expression and functional analysis of formate dehydrogenase in Klebsiella pneumoniae. Acta Microbiologica Sinica, 2007, 47 C1): 64 ⁇ 68] obtained from the C. boidinii genome with reduced form
- the formate I (NADH 2 ) regenerating function of the formate dehydrogenase gene, the formic acid dehydrogenase recombinant plasmid was constructed, and the NADH 2 regeneration system was constructed for the first time in the PDO production strain K. pneumoniae.
- the object of the present invention is to provide a method for constructing genetic engineering bacteria fermentation to jointly produce PDO, BDO and PHP.
- PDO producing bacteria knock out D-type lactate dehydrogenase, introduce coenzyme A-dependent aldehyde dehydrogenase and poly
- the hydroxy fatty acid synthase gene increases the synthesis of NADH 2 in cells, reduces the yield of unproductive by-product lactic acid, and increases the yield of beneficial by-product BDO.
- the method for constructing genetically engineered bacteria fermentation combined with fermentation to produce PDO, BDO and PHP (as shown in Fig. 2) used in the present invention comprises the steps of: knocking out the D-type lactate dehydrogenase gene in a wild strain producing PDO, introducing Coenzyme A-dependent aldehyde dehydrogenase and polyhydroxy fatty acid synthase gene, constructing genetically engineered bacteria for fermentation combined production of PDO, BDO and PHP; adopting aerobic fermentation and mixing and adding glycerol and alkali solution to the fermentation regulation mode; And the fermentation process is carried out by membrane filtration, electrodialysis, concentration, rectification and the like to separate the product extraction process of the product PDO and BDO and PHP.
- the specific contents are as follows:
- step B Using the genomic sample purified in step A as a template, primers were designed based on the D-type lactate dehydrogenase gene, and PCR (polymerase chain reaction) amplification experiments were carried out.
- the PCR product D-type lactate dehydrogenase gene fragment is purified and ligated to a cloning vector (eg, pMD18-T-vector).
- a cloning vector eg, pMD18-T-vector
- PHA synthase (PhaC) gene fragment derived from Ralstonia or Cupriavidus was ligated with PAD_pDK6 to construct the recombinant vector PAD_PhaC_pDK6 (Fig. 3).
- the PAD_PhaC_pDK6 recombinant vector was transformed into the competent cells of the engineered bacteria in which the D-type lactate dehydrogenase gene was knocked out in the step (1), and the positive clone was identified and isolated, which was the target strain.
- the constructed genetically engineered bacteria were cultured on a solid medium for 16 to 24 hours, and then placed in a seed culture medium at 30 to 37 ° C for aerobic culture, and the fermentation amount of glycerol was used as a fermentation substrate at an inoculation amount of 1% to 5%. Medium. Fermentation temperature 30 ⁇ 37 °C.
- the glycerol and alkali solution (1:0.05 ⁇ 1.0) were coupled and fed to control the fermentation. The pH value was controlled at 5.0 ⁇ 8.0, and the flow was stopped after 40 ⁇ 60h. Until the end of the fermentation.
- the fermentation broth is subjected to microfiltration and ultrafiltration.
- the filtrate is desalted by electrodialysis. After desalting, it is rich in PDO.
- the light chamber liquid of BDO is separated by concentration and rectification to separate the product PDO and BDO.
- the resulting cells were filtered for extraction of PHP.
- the salt-rich concentrated chamber liquid from electrodialysis is concentrated and crystallized to obtain an organic acid salt such as sodium succinate, which can also be used as one of the products, and the crystallization mother liquid returns to the pre-electrodialysis.
- the wild strains for constructing genetically engineered bacteria according to the present invention include strains capable of producing PDO, such as Klebsiella, Clostridium citrate, Enterobacter, and Serratia.
- the genetically engineered fermentation substrate constructed is glycerin, glycerol fermentation broth, biodiesel by-product crude glycerin or by-product crude in the soap industry.
- step 2 the fermentation is carried out by aerobic fermentation, and a method of mixing and adding fermentation of glycerin and an alkali solution is employed.
- the genetically engineered bacteria can be simultaneously fermented to produce PDO, BDO and PHP.
- the fermentation process D-type milk
- the acid is significantly reduced or not produced, and the post-product extraction process is thus simplified, reducing the cost of energy consumption and post-extraction;
- BDO and PHP are extracted as products, which increases the added value of the product and improves the utilization of raw materials. Reduced production costs;
- the introduction of PHP significantly increased the NADH 2 content of the bacteria, which is conducive to the synthesis of PDO.
- the invention can also be used in the co-production of PDO, BDO and PHP.
- Figure 1 shows the glycerol metabolic pathway of PHP in microbial cells.
- HOCH2CH2CH20H is glycerol
- HOCH2CH2CHO is 3-hydroxypropionaldehyde
- HOCH2CH2CO-CoA is 3-hydroxypropionyl-CoA
- Poly(3-Hydroxy-Propionic acid) is poly-3-hydroxypropionic acid
- CoA is coenzyme A
- NAD/ NADH is coenzyme I.
- Figure 2 shows the glycerol fermentation co-production of PHP, PDO and BDO.
- Glycerol is glycerol
- 3-Hy droxypropionaldehy de is 3-light propionaldehyde
- 3-Hydroxy-propionyl-Co A is 3-light-propionyl-CoA
- Poly(3-Hydroxy-propionic acid) is poly 3-hydroxyl Propionic acid
- 1,3 -Propanediol is 1,3-propanediol
- Pyruvate is pyruvic acid
- Lactate is lactic acid
- Acetolactate is acetolactate
- Acetoin is 3-hydroxybutanone
- 2,3-Butanediol is 2,3-butanediol.
- Figure 3 shows the recombinant plasmid PAD_PhaC_pDK6.
- Figure 4 shows the flow chart of PDO, BDO, and PHP product extraction. detailed description
- the method for synthesizing genetically engineered bacteria to jointly produce PDO, BDO and poly- ⁇ -hydroxypropionic acid comprises knocking out a D-type lactate dehydrogenase gene and introducing a coenzyme-dependent aldehyde dehydrogenase in a wild strain producing PDO And polyhydroxyalkanoate synthase gene, constructing genetically engineered bacteria for producing PDO, BDO and PHP by fermentation; fermenting by fermentation regulation method of mixing and feeding glycerin and alkali solution; and filtering the fermentation broth through membrane, electrodialysis , concentration, distillation and other steps to separate the product extraction process of product PDO and BDO and PHP.
- Genomic DNA was extracted from Klebsiella HR526 as a starting strain, and a pair of primers GGAATTCACGGTTGCGAACGGTATGTA and GCTCTAGAAGTGGTCTCCGAAATGCTGA was subjected to PCR amplification experiments, and the 5' ends of the primers contained EcoRI and Xbal endonuclease sites, respectively.
- the PCR product D-type lactate dehydrogenase gene fragment was purified and sequenced. The results were as follows:
- the above gene fragment was ligated to the cloning vector pMD 18-T-vector.
- the positive clone vector LDH-pMD18-T-tector was screened, and LDH-pMD18-T-tector was double-digested with EcoRI and Xbal.
- the recovered fragment was ligated with pGPKm vector which had been digested with the same endonuclease (EcoRI and Xbal). It was then transformed into E. coli SM10 competent cells by electroporation.
- the SM10 strain containing the recombinant plasmid LDH-pGPKm was subjected to a parental exchange experiment with the wild-type strain, and the strain having the D-type lactate dehydrogenase gene deletion was selected using the kanamycin resistance gene on the pGPKm vector as a selection marker.
- PAD CoA-Dependent Proionaldehyde Dehydrogenase
- Primers were designed. For: 5-GCT GAATTC ATGAATACAGCAGAACTGGA-3 and 5-GGCGGTACC TTAGCGAATGGAAAAACCGT-3).
- the recombinant expression vector PAD_pDK6 was constructed by ligating the vector pDK6 with the help of EcoRI and Kpnl endonuclease.
- the polyhydroxy acid fatty acid synthase gene fragment derived from Ralstonia eutropha digested with Xba I and B Hind III was ligated with the vector PAD_pDK6 to construct a recombinant vector PAD_PhaC_pDK6.
- the electroporation method was transformed into the competent cells of the engineered bacteria which were knocked out in the step (1) and the D-type lactate dehydrogenase gene was knocked out, and the positive clone was identified and isolated, which was the target strain HR526G.
- Fermentation method The genetically engineered bacteria were cultured on a solid medium for 24 hours, and the strain was inserted into a seed medium containing 30 g/L glycerol (250 ml flask, liquid volume 100 ml), culture temperature 37 °C, shaker speed 150rpm, aerobic culture for 24h. A fermented medium containing 30 g/l of initial glycerol was introduced at a 5% inoculation amount. The fermentation was carried out using a 5 L fermenter at a fermentation temperature of 37 °C.
- the glycerin and NaOH solution (1:0.1) were coupled and flowed, the pH was controlled at 6.0, the aeration was 0.2wm air, and the rotation speed was 150rpm. After 40h, the flow was stopped and the fermentation was completed.
- OD 65()nm reached 11; PHP content was 1.46% (g/g cell); PDO: 42g/l; BDO: 14g/l, lactic acid was not detected.
- the fermentation broth is filtered through a membrane, and the filtrate is separated by electrodialysis, concentration, distillation, distillation, and the like to separate the product PDO and BDO.
- the resulting cells were filtered for extraction of PHP.
- Product PDO extraction yield 85 %.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Procédé de co-production de 1,3-propanediol (PDO), 2,3-butanediol (BDO) et d'acide polyhydroxypropionique (PHP) par l'intermédiaire d'une fermentation par des bactéries produites par génie génétique. Ce procédé consiste à: désactiver par knock-out la lactate déshydrogénase de type D provenant de bactéries productrices de PDO; introduire des gènes d'aldéhyde déshydrogénase dépendante du coenzyme A et de synthase d'acides gras polyhydroxylés; construire des bactéries par génie génétique pour produire PDO, BDO et PHP; effectuer une fermentation aérobie et régler la fermentation par apport d'un mélange coulant de glycérine et d'une solution basique; filtrer le bouillon de fermentation au moyen d'une membrane et le traiter par électrodialyse, concentration et rectification séparant PDO, BDO et PHP. Les bactéries obtenues par génie génétique peuvent produire simultanément PDO, BDO et PHP, ce qui augmente le rapport d'utilisation des matières premières, limite les coûts, diminue la génération de produits secondaires à base de lactate, simplifie la technique de post-extraction, abaisse les coûts d'extraction et augmente la génération de nicotinamide adénine dinucléotide 2 (NADH2) pendant l'introduction de PHP.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810105722.8 | 2008-05-04 | ||
CN2008101057228A CN101307336B (zh) | 2008-05-04 | 2008-05-04 | 构建基因工程菌发酵联产pdo、bdo和php的方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009140929A1 true WO2009140929A1 (fr) | 2009-11-26 |
Family
ID=40124014
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2009/072615 WO2009140929A1 (fr) | 2008-05-04 | 2009-07-03 | Procédé de co-production de 1,3-propanediol, 2,3-butanediol et d'acide polyhydroxypropionique par fermentation de bactéries produites par génie génétique |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101307336B (fr) |
WO (1) | WO2009140929A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102154387A (zh) * | 2010-12-27 | 2011-08-17 | 山东大学 | 利用生物柴油副产物生产琥珀酸和聚羟基脂肪酸酯的方法 |
CN114958928A (zh) * | 2022-02-28 | 2022-08-30 | 江苏大学 | 一种基因工程菌发酵联产3-羟基丙酸和1,3-丙二醇的方法 |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101307336B (zh) * | 2008-05-04 | 2011-08-17 | 清华大学 | 构建基因工程菌发酵联产pdo、bdo和php的方法 |
US8129169B2 (en) * | 2009-06-04 | 2012-03-06 | Genomatica, Inc. | Microorganisms for the production of 1,4-butanediol and related methods |
US8227217B2 (en) | 2009-11-17 | 2012-07-24 | Tsinghua University | Methods and genetically engineered micro-organisms for the combined production of PDO, BDO and PHP by fermentation |
KR20120099315A (ko) * | 2011-01-26 | 2012-09-10 | 삼성전자주식회사 | 3-하이드록시프로피온산 및 1,3-프로판디올 동시 생산용 재조합미생물 |
CN104531786A (zh) * | 2014-12-10 | 2015-04-22 | 燃点科技(天津)有限公司 | 一种应用乙酰辅酶a合成聚3-羟基丙酸的方法 |
CN108522290A (zh) * | 2017-03-02 | 2018-09-14 | 云南纳博生物科技有限公司 | 一种自发光烟草及转基因方法 |
CN118834117A (zh) * | 2024-04-29 | 2024-10-25 | 苏州苏震生物工程有限公司 | 一种2,3-丁二醇的分离方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1348007A (zh) * | 2001-04-27 | 2002-05-08 | 大连理工大学 | 一种微生物微氧发酵生产1,3-丙二醇的方法 |
CN1763210A (zh) * | 2005-10-20 | 2006-04-26 | 清华大学 | 微生物好氧发酵生产1,3-丙二醇的方法 |
CN100999742A (zh) * | 2007-01-09 | 2007-07-18 | 清华大学 | 一种发酵生产1,3-丙二醇的高产工艺 |
CN101307336A (zh) * | 2008-05-04 | 2008-11-19 | 清华大学 | 构建基因工程菌发酵联产pdo、bdo和php的方法 |
-
2008
- 2008-05-04 CN CN2008101057228A patent/CN101307336B/zh not_active Expired - Fee Related
-
2009
- 2009-07-03 WO PCT/CN2009/072615 patent/WO2009140929A1/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1348007A (zh) * | 2001-04-27 | 2002-05-08 | 大连理工大学 | 一种微生物微氧发酵生产1,3-丙二醇的方法 |
CN1763210A (zh) * | 2005-10-20 | 2006-04-26 | 清华大学 | 微生物好氧发酵生产1,3-丙二醇的方法 |
CN100999742A (zh) * | 2007-01-09 | 2007-07-18 | 清华大学 | 一种发酵生产1,3-丙二醇的高产工艺 |
CN101307336A (zh) * | 2008-05-04 | 2008-11-19 | 清华大学 | 构建基因工程菌发酵联产pdo、bdo和php的方法 |
Non-Patent Citations (3)
Title |
---|
HAO, J. ET AL.: "Desalination of Fermented Broth Containing 1,3-Propanediol by Electrodialysis.", THE CHINESE JOURNAL OF PROCESS ENGINEERING, vol. 5, no. 1, February 2005 (2005-02-01), pages 36 - 39 * |
QI, W.T. ET AL.: "Progress in Metabolic Pathway and Genetic Regulation of Glycerol Bioconversion to 1, 3-propanediol.", JOURNAL OF CHINA BIOTECHNOLOGY., vol. 23, no. 2, February 2003 (2003-02-01), pages 64 - 68 * |
YANG, G ET AL.: "Fermentation of 1,3-propanediol by a lactate deficient mutant of Klebsiella oxytoca under microaerobic conditions.", APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, vol. 73, no. 5, January 2007 (2007-01-01), pages 1017 - 1024 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102154387A (zh) * | 2010-12-27 | 2011-08-17 | 山东大学 | 利用生物柴油副产物生产琥珀酸和聚羟基脂肪酸酯的方法 |
CN102154387B (zh) * | 2010-12-27 | 2013-01-30 | 山东大学 | 利用生物柴油副产物生产琥珀酸和聚羟基脂肪酸酯的方法 |
CN114958928A (zh) * | 2022-02-28 | 2022-08-30 | 江苏大学 | 一种基因工程菌发酵联产3-羟基丙酸和1,3-丙二醇的方法 |
CN114958928B (zh) * | 2022-02-28 | 2024-05-14 | 江苏大学 | 一种基因工程菌发酵联产3-羟基丙酸和1,3-丙二醇的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101307336A (zh) | 2008-11-19 |
CN101307336B (zh) | 2011-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zeng et al. | Microbial production of diols as platform chemicals: recent progresses | |
US8227217B2 (en) | Methods and genetically engineered micro-organisms for the combined production of PDO, BDO and PHP by fermentation | |
CN101307336B (zh) | 构建基因工程菌发酵联产pdo、bdo和php的方法 | |
Kaur et al. | Advances in biotechnological production of 1, 3-propanediol | |
Ghaffar et al. | Recent trends in lactic acid biotechnology: a brief review on production to purification | |
EP1897955B1 (fr) | Procédé de préparation du 1,3-propanediol et du 2,3-butanediol à partir d'amidon brut | |
CN112662637B (zh) | 一种甲酸脱氢酶突变体及其制备方法和应用 | |
CN102199570B (zh) | 构建基因工程菌以增强微生物发酵甘油产1,3-丙二醇的方法 | |
CN101255405A (zh) | 新构建的高产苹果酸基因工程菌及其生产苹果酸的方法 | |
CN118546852B (zh) | 一种高效共利用葡萄糖、木糖生产丁二酸的基因工程菌及其应用 | |
CN105051181B (zh) | 2,3-丁二醇的生成能力增加的重组微生物及利用其的2,3-丁二醇的制备方法 | |
CN106190936A (zh) | 一种菌及其构建方法和应用 | |
CN105950529A (zh) | 产3-羟基丙酸的重组谷氨酸棒杆菌、其构建方法及应用 | |
CN101381696B (zh) | 构建基因工程菌增强1,3-丙二醇生产菌株抗逆性的方法 | |
CN1246465C (zh) | 微生物两段发酵法由甘油生产1,3-丙二醇和2,3-丁二醇 | |
CN101205541B (zh) | 重组表达载体和用其转化的宿主细胞发酵甘油高产1,3-丙二醇的方法 | |
CN101397547B (zh) | 构建荚膜缺失的克雷伯氏菌的方法 | |
CN100491537C (zh) | 微生物好氧发酵生产1,3-丙二醇的方法 | |
CN106190901B (zh) | 一种菌及其获取方法和应用 | |
US8563283B2 (en) | Strains of Escherichia coli modified by metabolic engineering to produce chemical compounds from hydrolyzed lignocellulose, pentoses, hexoses and other carbon sources | |
de Cárdenas et al. | Production of organic acids via fermentation of sugars generated from lignocellulosic biomass | |
CN115851474A (zh) | 多拷贝整合与高密度发酵合成白藜芦醇的方法 | |
CN111394396B (zh) | 一种微生物利用甘油发酵生产1,3-丙二醇的方法 | |
WO2022088263A1 (fr) | Escherichia coli recombinant pour production efficace d'acide succinique et procédé de construction pour escherichia coli recombinant | |
EP3583221B1 (fr) | Consortium microbien comprenant des clostridia pour la production de 1,3-propanediol à partir de glycérol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09749472 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09749472 Country of ref document: EP Kind code of ref document: A1 |